Startup

ND Biosciences

Description

ND Biosciences is a spinoff from the Swiss Federal Institute of Technology in Lausanne (EPFL), dedicated to developing next-generation therapeutics for neurodegenerative diseases (NDs) such as Parkinson's and Alzheimer's Disease. Leveraging over 15 years of research, ND Biosciences has created an integrated suite of novel, validated, and patented drug-discovery platforms. These platforms accurately replicate the diversity, structural, and biochemical properties of pathogenic protein aggregates observed in patient brains, enabling more precise antigen generation for drug development. By utilizing cellular models that mimic different stages of protein aggregation, including early and terminal stages leading to neurodegeneration, ND Biosciences can assess efficacy and identify next-generation hits using translationally-relevant models.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.